510(k) device
Diazyme Human Kappa (k) Free Light Chain Assay
Diazyme Laboratories, Inc. · Kappa, Antigen, Antiserum, Control (DFH, Class II) · First FDA decision Nov 18, 2016, newest Dec 19, 2025Cancer detection and genomic testing
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
0
Naming "Diazyme Human"
MAUDE reports
0
Brand "Diazyme Human", since 2015
PubMed studies
0
Mentioning "Diazyme Human"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Diazyme Human Kappa (k) Free Light Chain Assay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay510(k)
K253358 · Decided Dec 19, 2025 · 80 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Diazyme Human", any status and sponsor, newest update first.
No registered device study names "Diazyme Human".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Diazyme Human", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DFH
63 reports: 53 malfunction, 10 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Diazyme Human"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DFH.
- N Latex FLC kappa, N Latex FLC lambdaSiemens Healthcare Diagnostics Products GmbH · 510(k) 2022
- Freelite Human Kappa and Lambda Free Diagnostic Test Kits for Use on the Roche Cobas Integra 400/400 Plus Analyzer KitThe Binding Site, Ltd. · 510(k) 2007
- Optilite® Freelite Mx Kappa Free KitThe Binding Site Group , Ltd. · 510(k) 2025
- FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2Sebia · 510(k) 2024
- Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitThe Binding Site, Ltd. · 510(k) 2024
- Optilite FreeLite Kappa Free Kit, Optilite Freelite Lambda Free KitThe Binding Site Group , Ltd. · 510(k) 2015
- Human Kappa and Lambda Free Kitfor Use on the Spa Plus AnalyserThe Binding Site Group , Ltd. · 510(k) 2013
- Kappa Light ChainsSENTINEL CH. SpA · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.